ECULIZUMAB and PYREXIA

Overview

PYREXIA is the #6 most commonly reported adverse reaction for ECULIZUMAB, manufactured by Alexion Pharmaceuticals Inc.. There are 2,383 FDA adverse event reports linking ECULIZUMAB to PYREXIA. This represents approximately 2.5% of all 94,110 adverse event reports for this drug.

Patients taking ECULIZUMAB who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PYREXIA is a less commonly reported adverse event for ECULIZUMAB, but still significant enough to appear in the safety profile.

Other Side Effects of ECULIZUMAB

In addition to pyrexia, the following adverse reactions have been reported for ECULIZUMAB:

• FATIGUE — 5,822 reports
• OFF LABEL USE — 4,574 reports
• HAEMOGLOBIN DECREASED — 3,897 reports
• HEADACHE — 3,447 reports
• DEATH — 2,562 reports
• DYSPNOEA — 2,148 reports
• ASTHENIA — 1,992 reports
• NAUSEA — 1,972 reports
• DRUG INEFFECTIVE — 1,878 reports
• HAEMOLYSIS — 1,844 reports

Other Drugs Associated with PYREXIA

The following drugs have also been linked to pyrexia in FDA adverse event reports:

Does ECULIZUMAB cause PYREXIA?

PYREXIA has been reported as an adverse event in 2,383 FDA reports for ECULIZUMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PYREXIA with ECULIZUMAB?

PYREXIA accounts for approximately 2.5% of all adverse event reports for ECULIZUMAB, making it a notable side effect.

What should I do if I experience PYREXIA while taking ECULIZUMAB?

If you experience pyrexia while taking ECULIZUMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages